Aspen Aerogels (ASPN) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
25 Feb, 2026Executive summary
2025 was a transitional year with a reset in North American EV demand, significant cost reductions, and a focus on liquidity and strategic review to maximize shareholder value.
Full year 2025 revenue was $271.1 million, with Q4 revenue at $41.3 million; both thermal barrier and energy industrial segments saw sharp declines year-over-year.
Organizational streamlining and $75 million in fixed cost reductions positioned the company for effective operation in a resetting EV market.
Strategic review underway to evaluate long-term positioning, capital allocation, and adjacent growth opportunities such as BESS, with Piper Sandler & Co. as advisor.
Strong momentum in Europe with seven OEM design wins, Volvo Cars award, and a robust pipeline supporting multi-year revenue growth.
Financial highlights
Q4 2025 revenue was $41.3 million; $25.3 million from energy industrial, $16.1 million from thermal barrier.
Full year 2025 revenue totaled $271.1 million; $102.2 million from energy industrial, $168.9 million from thermal barrier.
Q4 GAAP net loss was $72.9 million (adjusted net loss $27.7 million); full year GAAP net loss was $389.6 million (adjusted net loss $40.5 million).
Adjusted EBITDA for 2025 was $2.9 million; Q4 adjusted EBITDA was negative $18 million.
Ended 2025 with $158.6 million in cash and cash equivalents.
Outlook and guidance
Q1 2026 revenue expected between $35 million and $40 million, with $25 million from energy industrial.
Q1 2026 net loss projected between $20 million and $23 million; adjusted EBITDA between negative $13 million and negative $10 million.
Full-year 2026 capital expenditures expected to be under $10 million.
Sequential revenue growth anticipated through 2026, driven by GM production normalization, European OEM ramp, and 20% energy industrial growth.
Adjusted EBITDA breakeven targeted at $175 million revenue by 2027, with incremental EBITDA margin of 50%-60% above breakeven.
Latest events from Aspen Aerogels
- Raised European revenue outlook, robust cost controls, and dual supply strategy drive growth.ASPN
Oppenheimer 29th Annual Technology, Internet & Communications Conference - Q2 2026 revenue up 32% to $49.8M, with strong Thermal Barrier growth and positive Q3 outlook.ASPN
Q2 2026 - Strong margin gains, new OEM launches, and DOE-backed expansion drive robust growth outlook.ASPN
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 2024 - All proposals passed, including director elections and board declassification.ASPN
AGM 2026 - Q1 2026 revenue dropped, but net loss improved and strong cash reserves support recovery.ASPN
Q1 2026 - Virtual annual meeting to vote on directors, auditor, compensation, and board structure.ASPN
Proxy filing - Proxy covers director elections, auditor ratification, executive pay, and board declassification.ASPN
Proxy filing - Annual meeting covers director elections, pay, auditor ratification, and board declassification.ASPN
Proxy Filing - Record 2024 revenue, margin expansion, and capital-light strategy support resilient outlook.ASPN
Q4 2024